AEGiS-UPI: Japanese scientists introduce new HIV drug United Press InternationalImportant note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article




Japanese scientists introduce new HIV drug

United Press International - July 6, 2005


KOBE, Japan - Japanese researchers have developed a durable new drug that blocks HIV from entering human cells and causes almost no side effects.

The new drug, code named AK602, was unveiled by Hiroaki Mitsuya, leader of the research team at Kumamoto University, at the International Congress on AIDS in Asia and the Pacific in Kobe Tuesday, the Asahi Shimbun reported Wednesday.

The drug's main feature is that it shuts out the AIDS virus at the point when it tries to intrude into a human cell.

Current AIDS medications often lose their effectiveness after a few days due to the virus' resistance, but the AK602 reacts to human cells instead of attacking the virus, said Mitsuya, a university professor.

When the new drug becomes attached to the protein that acts as an entrance into human cells for the AIDS virus, it can prevent HIV from entering.

The researchers conducted clinical tests on 40 AIDS patients in the United States. When the patients took 0.02 ounces of AK602 twice a day for 10 days, the number of HIV viruses dropped to an average of 1 percent.

Almost no side effects were reported, the professor said.


050706
UP050705


Copyright © 2005 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .